artificial intelligence (Riegler Kirstein GmbH)
90
Structured Review
Riegler Kirstein GmbH
artificial intelligence
Artificial Intelligence, supplied by Riegler Kirstein GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/artificial+intelligence/artificial+intelligence/pmc11211808-2-10-0
Average 90 stars, based on 1 article reviews
Artificial Intelligence, supplied by Riegler Kirstein GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/artificial+intelligence/artificial+intelligence/pmc11211808-2-10-0
Average 90 stars, based on 1 article reviews
artificial intelligence - by Bioz Stars,
2026-11
90/100 stars
Images
1) Product Images from "Potential for artificial intelligence in medicine and its application to male infertility"
Article Title: Potential for artificial intelligence in medicine and its application to male infertility
Journal: Reproductive Medicine and Biology
doi: 10.1002/rmb2.12590
Figure Legend Snippet: AI models in male infertility.
Techniques Used: Comparison, Selection, Extraction
Related Articles
Biomarker Discovery:Article Title: The effect of day 5 blastocyst assessment timing on live birth prediction and development of a prediction algorithm. Article Snippet: Research question: Does variation in day 5 assessment timing confound live birth prediction using snapshot blastocyst morphology and is it possible to develop a numerical prediction algorithm?. Design: Retrospective multicentre cohort study including 4851 autologous oocyte single day 5 fresh embryo transfers performed at 11 Monash IVF clinics between 2016 and 2020.. Repeat cycles of the same patients were excluded to avoid clustering effects in regression analysis. other:Article Title: Artificial intelligence in corneal diseases: A narrative review. Article Snippet: Corneal diseases represent a growing public health burden, especially in resource-limited settings lacking access to specialized eye care.. Artificial intelligence (AI) offers promising solutions for automating the diagnosis and management of corneal conditions.. This narrative review examines the application of AI in corneal diseases, focusing on keratoconus, infectious keratitis, pterygium, dry eye disease, Fuchs endothelial corneal dystrophy, and corneal transplantation. |